These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7351289

  • 1. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
    Reed JS, Meredith SC, Nemchausky BA, Rosenberg IH, Boyer JL.
    Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
    [Abstract] [Full Text] [Related]

  • 2. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D.
    Herlong HF, Recker RR, Maddrey WC.
    Gastroenterology; 1982 Jul; 83(1 Pt 1):103-8. PubMed ID: 6978827
    [Abstract] [Full Text] [Related]

  • 3. Response of uremic osteoid to vitamin D.
    Memmos DE, Eastwood JB, Harris E, O'Grady A, de Wardener HE.
    Kidney Int Suppl; 1982 May; 11():S50-4. PubMed ID: 6956774
    [Abstract] [Full Text] [Related]

  • 4. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
    Kaplan MM, Goldberg MJ, Matloff DS, Neer RM, Goodman DB.
    Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D deficiency and bone disease in patients with Crohn's disease.
    Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH.
    Gastroenterology; 1982 Dec; 83(6):1252-8. PubMed ID: 6982188
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis.
    Guañabens N, Parés A, Mariñoso L, Brancós MA, Piera C, Serrano S, Rivera F, Rodés J.
    Am J Gastroenterol; 1990 Oct; 85(10):1356-62. PubMed ID: 2220729
    [Abstract] [Full Text] [Related]

  • 7. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.
    Compston JE, Horton LW, Thompson RP.
    Gut; 1979 Feb; 20(2):133-6. PubMed ID: 311747
    [Abstract] [Full Text] [Related]

  • 8. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
    Malluche HH, Goldstein DA, Massry SG.
    J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
    [Abstract] [Full Text] [Related]

  • 9. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.
    Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ.
    Gastroenterology; 1982 Jul; 83(1 Pt 1):97-102. PubMed ID: 7075948
    [Abstract] [Full Text] [Related]

  • 10. Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.
    Long RG, Varghese Z, Meinhard EA, Skinner RK, Wills MR, Sherlock S.
    Br Med J; 1978 Jan 14; 1(6105):75-7. PubMed ID: 620204
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.
    Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B.
    Hepatology; 1984 Jan 14; 4(1):1-8. PubMed ID: 6693061
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis.
    Compston JE, Thompson RP.
    Lancet; 1977 Apr 02; 1(8014):721-4. PubMed ID: 66519
    [Abstract] [Full Text] [Related]

  • 16. Oral 25-hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy.
    Compston JE, Horton LW.
    Gastroenterology; 1978 May 02; 74(5 Pt 1):900-2. PubMed ID: 640344
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.
    Dibble JB, Sheridan P, Hampshire R, Hardy GJ, Losowsky MS.
    Q J Med; 1982 May 02; 51(201):89-103. PubMed ID: 6981120
    [Abstract] [Full Text] [Related]

  • 19. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
    Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ.
    J Clin Invest; 1997 Sep 15; 100(6):1475-80. PubMed ID: 9294113
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease.
    Compston JE, Crowe JP, Wells IP, Horton LW, Hirst D, Merrett AL, Woodhead JS, Williams R.
    Dig Dis Sci; 1980 Jan 15; 25(1):28-32. PubMed ID: 7353448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.